Literature DB >> 13018235

A method for the quantitative determination in urinary extracts of C21 17:20-dihydroxy-20-methylsteroids.

R I COX.   

Abstract

Entities:  

Keywords:  STEROIDS/in urine

Mesh：

Substances：

Year:  1952        PMID： 13018235      PMCID： PMC1197996          DOI： 10.1042/bj0520339

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  7 in total

1.  The use of phenol glucuronide in the assay of beta-glucuronidase.

Authors:  L M Kerr; A F Graham; G A Levvy
Journal:  Biochem J       Date:  1948       Impact factor: 3.857

2.  The inhibition of beta-glucuronidase by saccharic acid and the role of the enzyme in glucuronide synthesis.

Authors:  M C Karunairatnam; G A Levvy
Journal:  Biochem J       Date:  1949       Impact factor: 3.857

3.  Proceedings of the Biochemical Society.

Authors: 
Journal:  Biochem J       Date:  1951-03       Impact factor: 3.857

4.  A diffusion method for the estimation of formaldehydogenic steroid.

Authors:  V P HOLLANDER; S DIMAURO; O H PEARSON
Journal:  Endocrinology       Date:  1951-11       Impact factor: 4.736

5.  The preparation and properties of glucuronidase, the fractionation of buffered water homogenates.

Authors:  L M H KERR; G A LEVVY
Journal:  Biochem J       Date:  1951-02       Impact factor: 3.857

6.  Isolation of 17-hydroxycorticosterone from blood obtained from adrenal veins of dogs.

Authors:  H REICH; D H NELSON; A ZAFFARONI
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

7.  Steroid excretion in a case of adrenocortical carcinoma. V. delta 5-Pregnenetriol-3 beta, 17 alpha, 20 alpha.

Authors:  H HIRSCHMANN; F B HIRSCHMANN
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157
  7 in total
  9 in total

1.  The adrenogenital syndrome with deficiency of 3 beta-hydroxysteroid dehydrogenase.

Authors:  A M BONGIOVANNI
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

2.  [Clinical importance of corticosteroid determination].

Authors:  E DICZFALUSY; G BIRKE; L O PLANTIN
Journal:  Klin Wochenschr       Date:  1956-03-01

3.  Partial characterization of urinary adrenocortical steroids in adrenal hyperplasia.

Authors:  W R EBERLEIN; A M BONGIOVANNI
Journal:  J Clin Invest       Date:  1955-08       Impact factor: 14.808

4.  Virilizing adrenal hyperplasia; a genetic and hormonal study.

Authors:  B CHILDS; M M GRUMBACH; J J VAN WYK
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

5.  The oxidation of corticosteroids with sodium bismuthate.

Authors:  C J BROOKS; J K NORYMBERSKI
Journal:  Biochem J       Date:  1953-10       Impact factor: 3.857

6.  A note on the hydrolysis of the urinary conjugated adrenocortical steroids by beta-glucuronidase preparations.

Authors:  R I COX; G F MARRIAN
Journal:  Biochem J       Date:  1953-04       Impact factor: 3.857

7.  The isolation of pregnane-3 alpha:17 alpha:20 alpha-triol from the urine of normal men.

Authors:  R I COX; G F MARRIAN
Journal:  Biochem J       Date:  1953-06       Impact factor: 3.857

8.  Androstenedione and its conversion to plasma testosterone in congenital adrenal hyperplasia.

Authors:  R Horton; S D Frasier
Journal:  J Clin Invest       Date:  1967-06       Impact factor: 14.808

9.  Pregnane 3 alpha, 17 alpha, 20 alpha-triol and pregnane-3 alpha, 17 alpha, 20 alpha,-triol-11-one excretion by patients with adrenocortical dysfunction.

Authors:  R I COX; M FINKELSTEIN
Journal:  J Clin Invest       Date:  1957-12       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.